Galmed Pharmaceuticals (FRA:GPH) Cash From Discontinued Investing Activities : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Galmed Pharmaceuticals's cash from discontinued investing activities for the three months ended in Sep. 2024 was €0.00 Mil. It means Galmed Pharmaceuticals received €0.00 Mil from discontinued investing activities. Galmed Pharmaceuticals's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Galmed Pharmaceuticals Cash From Discontinued Investing Activities Historical Data

The historical data trend for Galmed Pharmaceuticals's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Cash From Discontinued Investing Activities Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Galmed Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Galmed Pharmaceuticals Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Galmed Pharmaceuticals Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Galmed Pharmaceuticals's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galmed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (FRA:GPH) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

GLMD:USA

Address

16 Tiomkin Street, Tel Aviv, ISR, 6578317

Website

https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Galmed Pharmaceuticals Headlines

No Headlines